Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lance Cowey

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Drug Design, Development and Therapy|July 3, 2013
Profile of tivozanib and its potential for the treatment of advanced renal cell carcinomaC Lance Cowey
Dermatology and Therapy|July 27, 2013
Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyondC Lance Cowey
Dermatology and Therapy|September 21, 2015
The Rapid Emergence of Novel Therapeutics in Advanced Malignant MelanomaLijo John, C Lance Cowey
Current Oncology Reports|February 17, 2009
VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacyC Lance Cowey, W Kimryn Rathmell
Expert Opinion on Drug Discovery|July 22, 2010
Using Molecular Biology to Develop Drugs for Renal Cell CarcinomaC Lance Cowey, W Kimryn Rathmell
Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Molecularly targeted agents for renal cell carcinoma: the next generationC Lance Cowey, Thomas E Hutson
Cancer Management and Research|October 14, 2017
Challenging the standard of care in advanced melanoma: focus on pembrolizumabRaghad M Abdul-Karim, C Lance Cowey
Oncotargets and Therapy|November 5, 2010
New advancements and developments in treatment of renal cell carcinoma: focus on pazopanibC Lance Cowey, Guru Sonpavde, Thomas E Hutson
Urology|November 26, 2009
The loss of radiographic enhancement in primary renal cell carcinoma tumors following multitargeted receptor tyrosine kinase therapy is an additional indicator of responseC Lance Cowey, Julia R Fielding, W Kimryn Rathmell
Current Opinion in Oncology|April 3, 2009
Renal cell carcinomaJorge A Garcia, C Lance Cowey, Paul A Godley
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Drug Design, Development and Therapy|July 3, 2013
Profile of tivozanib and its potential for the treatment of advanced renal cell carcinomaC Lance Cowey
Dermatology and Therapy|July 27, 2013
Targeted therapy for advanced Basal-cell carcinoma: vismodegib and beyondC Lance Cowey
Dermatology and Therapy|September 21, 2015
The Rapid Emergence of Novel Therapeutics in Advanced Malignant MelanomaLijo John, C Lance Cowey
Current Oncology Reports|February 17, 2009
VHL gene mutations in renal cell carcinoma: role as a biomarker of disease outcome and drug efficacyC Lance Cowey, W Kimryn Rathmell
Expert Opinion on Drug Discovery|July 22, 2010
Using Molecular Biology to Develop Drugs for Renal Cell CarcinomaC Lance Cowey, W Kimryn Rathmell
Clinical Advances in Hematology & Oncology : H&O|June 17, 2010
Molecularly targeted agents for renal cell carcinoma: the next generationC Lance Cowey, Thomas E Hutson
Cancer Management and Research|October 14, 2017
Challenging the standard of care in advanced melanoma: focus on pembrolizumabRaghad M Abdul-Karim, C Lance Cowey
Oncotargets and Therapy|November 5, 2010
New advancements and developments in treatment of renal cell carcinoma: focus on pazopanibC Lance Cowey, Guru Sonpavde, Thomas E Hutson
Urology|November 26, 2009
The loss of radiographic enhancement in primary renal cell carcinoma tumors following multitargeted receptor tyrosine kinase therapy is an additional indicator of responseC Lance Cowey, Julia R Fielding, W Kimryn Rathmell
Current Opinion in Oncology|April 3, 2009
Renal cell carcinomaJorge A Garcia, C Lance Cowey, Paul A Godley
Pageof 5